Endoscopic tumor ablation of upper tract urothelial carcinoma (UTUC) allows for tumor control with the benefit of renal preservation but is impacted by intraoperative visibility. We sought to develop a computer vision model for real-time, automated segmentation of UTUC tumors to augment visualization during treatment.
We collected twenty videos of endoscopic treatment of UTUC from two institutions. Frames from each video (N=3387) were extracted and manually annotated to identify tumors and areas of ablated tumor. Three established computer vision models (U-Net, U-Net++ and UNext) were trained using these annotated frames and compared. Eighty percent of the data was used to train the models while 10% was used for both validation and testing. We evaluated the highest performing model for tumor and ablated tissue segmentation using a pixel-based analysis. The model and a video overlay depicting tumor segmentation were further evaluated intraoperatively.
All twenty videos (mean 36 seconds ± 58s) demonstrated tumor identification and 12 depicted areas of ablated tumor. The U-Net model demonstrated the best performance for segmentation of both tumors (AUC-ROC of 0.96) and areas of ablated tumor (AUC-ROC of 0.90). Additionally, we implemented a working system to process real-time video feeds and overlay model predictions intraoperatively. The model was able to annotate new videos at 15 fps.
Computer vision models demonstrate excellent real-time performance for automated upper tract urothelial tumor segmentation during ureteroscopy.
Journal of endourology. 2024 Apr 25 [Epub ahead of print]
Daiwei Lu, Amy M Reed, Natalie Pace, Amy Luckenbaugh, Maximilian Pallauf, Nirmish Singla, Ipek Oguz, Nicholas Kavoussi
Vanderbilt University School of Engineering, 541729, Computer Science, Nashville, Tennessee, United States; daiwei.lu@vanderbilt.edu., Vanderbilt University Medical Center, 12328, Department of Urology, Nashville, Tennessee, United States; amy.m.reed@vumc.org., Vanderbilt University Medical Center, 12328, Urology, Nashville, Tennessee, United States; natalie.pace@vumc.org., Vanderbilt University Medical Center, 12328, Nashville, Tennessee, United States; amy.n.luckenbaugh@vumc.org., Landeskrankenhaus Salzburg - Universitatsklinikum der Paracelsus Medizinischen Privatuniversitat, 31545, Universitätsklinik für Urologie und Andrologie, Müllner Hauptstraße 48, Salzburg, Salzburg, Austria, 5020; maximilian.pallauf@gmail.com., Johns Hopkins Medicine, 1501, Urology, Baltimore, Maryland, United States; Nsingla2@jhmi.edu., Vanderbilt University School of Engineering, 541729, Computer Science, Nashville, Tennessee, United States; ipek.oguz@vanderbilt.edu., Vanderbilt University Medical Center, 12328, Urology, 1211 Medical Center Drive, Nashville, Tennessee, United States, 37323; nicholas.l.kavoussi@vumc.org.
PubMed http://www.ncbi.nlm.nih.gov/pubmed/38661528